Randomized clinical trial: Nucleos(t)ide analogues improved survival of CHB-related HCC patients via reducing severity and progression of malignancy.
about
Randomized clinical trial: Nucleos(t)ide analogues improved survival of CHB-related HCC patients via reducing severity and progression of malignancy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 June 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Randomized clinical trial: Nucleos
@nl
Randomized clinical trial: Nuc ...... and progression of malignancy.
@en
type
label
Randomized clinical trial: Nucleos
@nl
Randomized clinical trial: Nuc ...... and progression of malignancy.
@en
prefLabel
Randomized clinical trial: Nucleos
@nl
Randomized clinical trial: Nuc ...... and progression of malignancy.
@en
P2093
P2860
P356
P1433
P1476
Randomized clinical trial: Nuc ...... and progression of malignancy.
@en
P2093
Huijuan Zhou
Liwen Chen
Rebecca Bao
Shisan Bao
Weiliang Tang
Xiaogang Xiang
P2860
P304
58553-58562
P356
10.18632/ONCOTARGET.10155
P407
P50
P577
2016-06-18T00:00:00Z